Showing results (51-60 of 76) with videos related to

Sort By:
Pageof 8
Immunobiology|December 1, 1994
Inhibitors of dipeptidyl peptidase IV (DP IV, CD26) specifically suppress proliferation and modulate cytokine production of strongly CD26 expressing U937 cellsD Reinhold, U Bank, F Bühling, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|February 1, 1997
Renal cell carcinomas produce IL-6, IL-10, IL-11, and TGF-beta 1 in primary cultures and modulate T lymphocyte blast transformationB Knoefel, K Nuske, T Steiner, et al.
Cytokine|October 1, 1996
Transforming growth factor beta 1 is significantly elevated in plasma of patients suffering from renal cell carcinomaU Junker, B Knoefel, K Nuske, et al.
Lymphology|January 25, 2013
Progressive lipo-lymphedema associated with increased activity of dermal fibroblasts in monoclonal gammopathy of undetermined significance: is there a causal relationship?A Thielitz, M Bellutti, B Bonnekoh, et al.
Advances in Experimental Medicine and Biology|June 13, 2000
Effects of nonapeptides derived from the N-terminal structure of human immunodeficiency virus-1 (HIV-1) Tat on suppression of CD26-dependent T cell growthS Wrenger, D Reinhold, J Faust, et al.
Alimentary Pharmacology & Therapeutics|February 5, 2015
Autoimmune gastritis in autoimmune thyroid diseaseM Venerito, M Radünz, K Reschke, et al.
Cytokine|July 6, 2000
Elevated plasma TGF-beta1 in renal diseases: cause or consequence?U Junker, C C Haufe, K Nuske, et al.
Advances in Experimental Medicine and Biology|June 13, 2000
N-terminal HIV-1 Tat nonapeptides as inhibitors of dipeptidyl peptidase IV. Conformational characterizationC Mrestani-Klaus, A Fengler, J Faust, et al.
Journal of Peptide Science : an Official Publication of the European Peptide Society|October 31, 1998
1H NMR conformational study on N-terminal nonapeptide sequences of HIV-1 Tat protein: a contribution to structure-activity relationshipsC Mrestani-Klaus, A Fengler, W Brandt, et al.
Urologia Internationalis|August 14, 1998
Increased transforming growth factor beta1 plasma level in patients with renal cell carcinoma: a tumor-specific marker?H Wunderlich, T Steiner, H Kosmehl, et al.
Pageof 8